List of nationally authorised medicinal products

Similar documents
Common Safety Indicators (CSIs) as reported by Member States Extracted on 18 October 2013 from ERAIL database (

Area Yield Production ha % TAV 100 kg/ha % TAV t % TAV

Sheep and goat numbers (preceding December)

December 2011 compared with November 2011 Industrial producer prices down by 0.2% in both euro area and EU27

September 2011 compared with August 2011 Industrial producer prices up by 0.3% in euro area Up by 0.4% in EU27

BUSINESS AND CONSUMER SURVEY RESULTS. Euro Area (EA) February 2014: Economic Sentiment broadly unchanged in the euro area and the EU

Consumer confidence indicator

BUSINESS AND CONSUMER SURVEY RESULTS. Euro Area (EA) European Union (EU)

BUSINESS AND CONSUMER SURVEY RESULTS

February 2014 Euro area unemployment rate at 11.9% EU28 at 10.6%

EUROPEAN FISHERIES IN FIGURES

External Drive Axis Packages

BUSINESS AND CONSUMER SURVEY RESULTS

May 2014 Euro area unemployment rate at 11.6% EU28 at 10.3%

Tracks TSL600SD/TSL1000SD/ TSL2000SD/TSL4000SD DX200. for MOTOMAN Robots with DX200 Controller. Controlled by.

Belgique/ Bulgaria Česká Danmark Deutschland Eesti Éire/Ireland Elláda España France Italia Kýpros Latvija Lietuva Luxembourg Magyarország

BUSINESS AND CONSUMER SURVEY RESULTS. August 2013: Economic Sentiment rises further in both the euro area and the EU

BUSINESS AND CONSUMER SURVEY RESULTS. September 2018: Economic Sentiment decreases in both the euro area and the EU

MOTOMAN GP-series. Handling & General Application. Controlled by YRC

June 2014 Euro area unemployment rate at 11.5% EU28 at 10.2%

BUSINESS AND CONSUMER SURVEY RESULTS. Euro Area (EA) European Union (EU) September 2015: Economic Sentiment improves in the euro area and the EU

March 2013 Euro area unemployment rate at 12.1% EU27 at 10.9%

First Trends H2020 vs FP7: winners and losers

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR ECONOMIC AND FINANCIAL AFFAIRS BUSINESS AND CONSUMER SURVEY RESULTS. August 2011

MOTOMAN Service Contracts

BUSINESS AND CONSUMER SURVEY RESULTS. Euro Area (EA) European Union (EU)

BUSINESS AND CONSUMER SURVEY RESULTS

BUSINESS AND CONSUMER SURVEY RESULTS

BUSINESS AND CONSUMER SURVEY RESULTS. February 2019: Economic Sentiment broadly stable in the euro area, down in the EU

BUSINESS AND CONSUMER SURVEY RESULTS. Euro Area (EA) June 2014: Economic Sentiment decreasing in the euro area, while stable in the EU

Protected designations of origin and protected geographical indications R. (UE) 1151/ /12/2013. Ranking. Totals

The 3 rd European Road Safety Action Programme

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR ECONOMIC AND FINANCIAL AFFAIRS BUSINESS AND CONSUMER SURVEY RESULTS. April 2011

DRINK-DRIVING IN THE EUROPEAN UNION

Next update will be this week as soon as possible. Thanks for your understanding

Adjusting and extending the LFS data used for the projections

TAXATION N 322 JC/ 49 /14 LC/ 39 /14 BARS/ 25 /14 WG-TX/ 2 /14 WG-CO2/ 23 /14 WG-EV/ 4 /14 WG-CSG/ 10 /14

Inflation Differentials in Europe. Balázs Égert Economics Department, OECD

Addendum to TSAP report #13. Markus Amann, Jens Borken-Kleefeld, Janusz Cofala, Zig Klimont, June 13, 2014

BUSINESS AND CONSUMER SURVEY RESULTS. November 2013: Economic Sentiment improves in the euro area and the EU

Single vehicle accidents

KEY DRIVERS AND SLOWERS OF PASSENGER CAR TRANSPORT (ENERGY) DEMAND IN THE EU-27

Publication of data. This report is published on a weekly basis.

C-eight QUICK START GUIDE & REGULATORY

EU Market Situation for Poultry. Civil Dialogue Group. 25 October 2016

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2006/42

Adding value to IRENA s REmap 2030 project using a European Electricity Model

Minutes. Meeting of the Member States Expert Group on AVAS for M & N category vehicles (E01295) 16 November 2016, Brussels

Single vehicle accidents

The Innovation Company. LTG Aktiengesellschaft. Technical Brochure. LTG Air Distribution. Highly-tight shut-off damper KLB

CARS 2020 Working Group Clean Vehicles: Electromobility and alternative fuels. 27 May 2013

New Challenges for the Transatlantic Cooperation N. LOHL, EASA

TEPZZ Z Z 85A_T EP A1 (19) (11) EP A1. (12) EUROPEAN PATENT APPLICATION published in accordance with Art.

Alcohol Interlocks and the fight against Drink-Driving

MOTOMAN SIA-series FS100. Flexible Applications with the SIA-series. Controlled by

MOTOMAN SDA-series FS100. Flexible Applications with the SDA-series. Controlled by

The European pigmeat sector. "Single CMO" Management Committee 17 September 2009

Survey on passengers satisfaction with rail services. Analytical report. Flash Eurobarometer 326 The Gallup Organization

Committing to the future. The digital manifold testo 550, ideal for all measurement work on refrigeration systems and heat pumps

EP A2 (19) (11) EP A2 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2012/42

*EP A1* EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2005/41

Spring forecasts : a tough 2009, but EU economy set to stabilise as support measures take effect

Denmark. Website. Contact points Flag State. Status of Conventions. EU Member State. Port State. Coastal State

EIOPA list of identified insurance groups for which a college of supervisors is in place 1

LANGUAGE, COPYRIGHT AND GEOGRAPHIC SEGMENTATION IN THE EU DIGITAL SINGLE MARKET: THE CASE OF APPLE ITUNES

Publication of data ,

Richway & Fuji Bio Inc Rev 5

1 Background and definitions

2009 Europe / US International Aviation Safety Conference

DOUBLE OCTOMILL TM PRODUCT RANGE

Market situation Sugar Market Observatory 12 April 2018

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2009/04

2016 PRODUCTS PRICE LIST AND SHIPPING SHIPPING AND HANDLING FOR CONTINENTAL U.S.A.

Road safety in Europe. Graziella Jost, ETSC, PIN Programme Manager

EUROPEAN UNION ENERGY AND TRANSPORT IN FIGURES Part 3 : TRANSPORT

COMMISSION IMPLEMENTING DECISION

TEPZZ A T EP A2 (19) (11) EP A2 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: F16H 47/04 ( )

EUROPEAN COMMISSION DIRECTORATE-GENERAL TAXATION AND CUSTOMS UNION Indirect Taxation and Tax administration Indirect taxes other than VAT

External and intra-european Union trade

(51) Int Cl.: B61F 5/38 ( ) (54) Two- axle bogie for railway vehicle with radially adjustable wheelsets with cross coupling

THE BALTIC SEA POWER RING CONNECTED: A GLANCE AT NORDBALT AND LITPOL LINK TODAY AND OUTLOOK FOR TOMORROW

Traffic Safety Basic Facts 2010

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 22 October 2015

THE ROAD SAFETY POLICY IN SPAIN. Rome, 9 th April 2009

Greening transport taxation

Implications of Biofuel Support Policies in Europe - A Quantitative Analysis in an Open Economy

SafetyNet. Based on data from CARE / EC. Building the European Road Safety Observatory Workpackage 1 Task 3 Deliverable No: D 1.20

Motorcycles and Mopeds

CHARGING INSTALL THE BATTERIES INTO THE CONTROLLER

Sustainability Transport Innovation Energy efficiency the key to railway innovation

TEPZZ 67_744A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: B60K 6/10 ( )

Internalisation of external costs

16.3 Value of payments processed by selected payment systems (total for the period)

DEMOGRAPHIC PERSPECTIVES AND IMPLICATIONS FOR VOCATIONAL EDUCATION AND TRAINING IN THE EUROPEAN UNION FINAL REPORT

TEPZZ 5 59 A T EP A2 (19) (11) EP A2 (12) EUROPEAN PATENT APPLICATION

The SafeCulture project Results on safety culture in professional transport in Greece

EUROPEAN ENERGY MASTER CLASS

TEPZZ ZZ9 78A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: B65D 85/804 ( )

TEPZZ Z6 Z79A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: G01L 19/14 ( ) G01L 19/00 (2006.

Transcription:

8 February 2018 EMA/88406/2018 Human Medicines Evaluation Division Active substance: benserazide / levodopa Procedure no.: PSUSA/00000330/201706 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact An agency of the European Union European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

Madopar "125" not available 6366 ROCHE A/S DK Madopar "125" not available 13503 ROCHE A/S DK Madopar 125 hörð hylki not available 731657 ROCHE A/S IS Madopar 125 töflur not available 890032 ROCHE A/S IS Madopar 250 töflur not available 812707 ROCHE A/S IS Madopar 250 hörð hylki not available 731877 ROCHE A/S IS Madopar 62,5 hörð not available 792435 ROCHE A/S IS hylki Madopar 100 mg + 25 not available 023142019 ROCHE S.P.A. IT mg capsule rigide Madopar 100 mg + 25 not available 023142045 ROCHE S.P.A. IT mg capsule rigide a rilascio prolungato Madopar 100 mg + 25 not available 023142058 ROCHE S.P.A. IT mg compresse dispersibili Madopar 100 mg/25 mg not available 1-21773 ROCHE AUSTRIA GMBH AT - lösliche Tabletten Madopar 100 mg/25 mg not available 1-22672 ROCHE AUSTRIA GMBH AT - Tabletten Madopar 100 mg/25 mg not available 00-0724 ROCHE LATVIJA SIA LV cietās kapsulas Madopar 100 mg/25 mg not available 9882 ROCHE OY FI depotkapslar Madopar 100 mg/25 mg not available 184197 ROCHE EESTI OÜ EE dispergeeruvad tabletid Madopar 100 mg/25 mg not available 00-0723 ROCHE LATVIJA SIA LV disperģējamās tabletes Madopar 100 mg/25 mg not available LT/1/94/0936/002 UAB "ROCHE LIETUVA" LT disperguojamosios tabletės Madopar 100 mg/25 mg Dispersible Tablets not available PL 00031/0221 ROCHE PRODUCTS LTD UK Madopar 100 mg/25 mg disperzibilne tablete not available H/96/00958/001 ROCHE FARMACEVTSKA DRUŽBA D.O.O. SI EMA/88406/2018 Page 2/12

Madopar 100 mg/25 mg not available OGYI-T-1157/02 ROCHE (MAGYARORSZÁG) HU diszpergálódó tabletta KFT Madopar 100 mg/25 mg not available MA060/00603 ROCHE PRODUCTS LTD MT Madopar 100 mg/25 mg not available PL 00031/0073 ROCHE PRODUCTS LTD UK Madopar 100 mg/25 mg not available LT/1/94/0936/003 UAB "ROCHE LIETUVA" LT kietosios kapsulės Madopar 100 mg/25 mg not available 403902 ROCHE EESTI OÜ EE kõvakapslid Madopar 100 mg/25 mg not available OGYI-T-1157/03 ROCHE (MAGYARORSZÁG) HU retard kemény kapszula KFT Madopar 100 mg/25 mg not available H/96/00958/002 ROCHE FARMACEVTSKA SI tablete DRUŽBA D.O.O. Madopar 100 mg/25 mg not available 9672 ROCHE OY FI tabletter Madopar 100mg/25mg not available PA 50/43/6 ROCHE PRODUCTS LTD IE Dispersible Tablets Madopar 12,5/50 not available 6694 F. HOFFMANN-LA ROCHE AG NO kapsler, harde Madopar 125 mg, 100 not available R/0950 ROCHE POLSKA SP.O.O. PL mg + 25 mg, kapsułki Madopar 125 mg, 100 not available 7487 ROCHE POLSKA SP.O.O. PL mg + 25 mg, tabletki do sporządzania zawiesiny doustnej Madopar 125 mg, not available RVG 19428 ROCHE NEDERLAND B.V. NL dispergeerbare tabletten Madopar 125 mg, not available RVG 12059 ROCHE NEDERLAND B.V. NL tabletten Madopar 125 tablete not available HR-H-771762650 ROCHE D.O.O. HR Madopar 200 mg + 50 mg compresse divisibili not available 023142033 ROCHE S.P.A. IT EMA/88406/2018 Page 3/12

Madopar 200 mg + 50 mg comprimidos Madopar 200 mg + 50 mg comprimidos - Tabletten comprimate tablete tabletes tabletės tabletid tabletta tabletter Madopar 200mg/50mg Madopar 25/100 kapsler, harde Madopar 250 kapsler, hårde Madopar 250 mg, 200 mg + 50 mg, tabletki Madopar 250 mg, tabletten not available 8557926 ROCHE FARMACÊUTICA QUÍMICA, LDA. PT not available 8557900 ROCHE FARMACÊUTICA PT QUÍMICA, LDA. not available 17.235 ROCHE AUSTRIA GMBH AT not available 8133/2006/01 ROCHE ROMANIA SRL RO not available MA060/00604 ROCHE PRODUCTS LTD MT not available PL 00031/0074 ROCHE PRODUCTS LTD UK not available H/96/00958/003 ROCHE FARMACEVTSKA SI DRUŽBA D.O.O. not available 96-0643 ROCHE LATVIJA SIA LV not available LT/1/94/0936/001 UAB "ROCHE LIETUVA" LT not available 046594 ROCHE EESTI OÜ EE not available OGYI-T-1157/01 ROCHE (MAGYARORSZÁG) HU KFT not available 8611 ROCHE OY FI not available PA 50/43/2 ROCHE PRODUCTS LTD IE not available 5967 F. HOFFMANN-LA ROCHE AG NO not available 6367 ROCHE A/S DK not available R/0951 ROCHE POLSKA SP.O.O. PL not available RVG 11605 ROCHE NEDERLAND B.V. NL EMA/88406/2018 Page 4/12

Madopar 250 tablety not available 27/391/01-C ROCHE S. R. O. CZ Madopar 250, tabletter not available 11363 ROCHE A/S DK Madopar 50 mg/12,5 mg not available 16.549 ROCHE AUSTRIA GMBH AT - Kapseln Madopar 50 mg/12.5 mg not available PL 00031/0220 ROCHE PRODUCTS LTD UK Dispersible Tablets Madopar 50 mg/12.5 mg not available MA060/00602 ROCHE PRODUCTS LTD MT Madopar 50 mg/12.5 mg not available PL 00031/0125 ROCHE PRODUCTS LTD UK Madopar 50mg/12.5mg not available PA 50/43/5 ROCHE PRODUCTS LTD IE Dispersible Tablets Madopar 62,5 kapsler, not available 9821 ROCHE A/S DK hårde Madopar 62,5 mg, 50 mg not available R/0949 ROCHE POLSKA SP.O.O. PL + 12,5 mg, kapsułki Madopar 62,5 mg, 50 mg not available 7486 ROCHE POLSKA SP.O.O. PL + 12,5 mg, tabletki do sporządzania zawiesiny doustnej Madopar 62,5 mg, not available RVG 08475 ROCHE NEDERLAND B.V. NL capsules Madopar 62,5 rozpustné not available 27/029/04-C ROCHE S. R. O. CZ tablety Madopar CR 100 mg/25 not available 1-19177 ROCHE AUSTRIA GMBH AT mg - Kapseln Madopar CR 100 mg/25 not available MA060/00601 ROCHE PRODUCTS LTD MT mg Prolonged Release Madopar CR 100 mg/25 not available PL 00031/0227 ROCHE PRODUCTS LTD UK mg Prolonged Release Madopar DEPOT 100 mg/25 mg hörð forðahylki not available 870211 ROCHE A/S IS EMA/88406/2018 Page 5/12

Madopar Depot 25/100 depotkapsler Madopar DEPOT, depotkapsler, hårde Madopar Dispersible 125 mg dispergovateľné tablety Madopar HBS 100 mg + 25 mg cápsulas de libertação prolongada Madopar HBS 100 mg/25 mg ilgstošās darbības cietās kapsulas Madopar HBS 100 mg/25 mg pailginto atpalaidavimo kietosios kapsulės Madopar HBS 100 mg/25 mg toimeainet prolongeeritult vabastavad kõvakapslid Madopar HBS 125 mg, capsules met gereguleerde afgifte Madopar HBS 125 mgtvrdé kapsuly s riadeným uvolnovaním Madopar HBS capsule cu eliberare modificată Madopar HBS capsule cu eliberare modificată Madopar HBS tvrdé tobolky s řízeným uvolňováním not available 7430 F. HOFFMANN-LA ROCHE AG NO not available 13087 ROCHE A/S DK not available 27/0156/00-S ROCHE SLOVENSKO S.R.O. SK not available 8402933 ROCHE FARMACÊUTICA QUÍMICA, LDA. not available 96-0353 ROCHE LATVIJA SIA LV not available LT/1/94/0936/004 UAB "ROCHE LIETUVA" LT not available 142896 ROCHE EESTI OÜ EE not available RVG 12489 ROCHE NEDERLAND B.V. NL not available 27/0168/89-C/S ROCHE SLOVENSKO S.R.O. SK not available 7678/2006/01 ROCHE ROMANIA SRL RO not available 7678/2006/02 ROCHE ROMANIA SRL RO not available 27/168/89-C ROCHE S. R. O. CZ PT EMA/88406/2018 Page 6/12

Madopar HBS, 100 mg + not available R/3775 ROCHE POLSKA SP.O.O. PL 25 mg, kapsułki Madopar Quick "125" not available 18676 ROCHE A/S DK Madopar Quick "62,5" not available 18675 ROCHE A/S DK Madopar Quick 62,5 not available 970268 ROCHE A/S IS lausnartöflur Madopar QUICK 100 not available 12242 ROCHE OY FI mg/25 mg lösliga tabletter Madopar Quick 125 not available 970269 ROCHE A/S IS lausnartöflur Madopar RETARD 100/25 not available 62.162 ROCHE FARMA, S.A. ES mg cápsulas duras de liberación prolongada Madopar Solubile not available 8052 F. HOFFMANN-LA ROCHE AG NO 12,5/50 oppløselige tabletter Madopar, 200 mg + 50 not available R/0952 ROCHE POLSKA SP.O.O. PL mg, kapsułki Madopar not available 85847/15/28.12.2016 ROCHE (HELLAS) SA GR MADOPAR 100 mg/25 not available 9882 ROCHE OY FI mg depotkapseli MADOPAR 100 mg/25 not available 9672 ROCHE OY FI mg tabletti Madopar 125 mg not available 6036937.00.00 ROCHE PHARMA AG DE Hartkapseln Madopar 125 mg T not available 6036937.00.01 ROCHE PHARMA AG DE Tabletten MADOPAR not available 8611 ROCHE OY FI 200 mg/50 mg tabletti Madopar 250 not available 52146 ROCHE FARMA S.A. ES EMA/88406/2018 Page 7/12

Madopar 250 mg Tabletten Levodopa 200 mg Benserazid 50 mg (als Benserazidhydrochlorid) Madopar 62,5 mg Hartkapseln Levodopa 50 mg Benserazid 12,5 mg (als Benserazidhydrochlorid) Madopar Depot Hartkapseln, retardiert Levodopa 100 mg Benserazid 25 mg (als Benserazidhydrochlorid) Madopar LT Tabletten zur Herstellung einer Suspension zum Einnehmen Levodopa 100 mg Benserazid 25 mg (als Benserazidhydrochlorid) MADOPAR QUICK 100 mg/25 mg liukeneva tabletti Madopark 100 mg/25 mg tabletter Madopark DEPOT 100 mg/25 mg depotkapslar, hårda Madopark Quick 100 mg/25 mg tabletter Madopark Quick mite 50 mg/12,5 mg tabletter not available 861.00.01 ROCHE PHARMA AG DE not available 861.00.00 ROCHE PHARMA AG DE not available 17010.00.00 ROCHE PHARMA AG DE not available 32582.01.00 ROCHE PHARMA AG DE not available 12242 ROCHE OY FI not available 10828 ROCHE AB SE not available 11479 ROCHE AB SE not available 12229 ROCHE AB SE not available 10951 ROCHE AB SE EMA/88406/2018 Page 8/12

Maдопар 100 mg/25 mg диспергиращи се таблетки Maдопар 200 mg/50 mg таблетки Modopar 125 (100 mg/25 mg), gélule Modopar 125 (100 mg/25 mg), gélule Modopar 125 (100 mg/25 mg), gélule Modopar 125 (100 mg/25 mg), gélule Modopar 125 (100 mg/25 mg), gélule Modopar 125 (100 mg/25 mg), gélule MODOPAR 125 DISPERSIBLE (100 mg/25 mg), comprimé sécable pour suspension buvable MODOPAR 125 DISPERSIBLE (100 mg/25 mg), comprimé sécable pour suspension buvable Modopar 250 (200 mg/50 mg), gélule Modopar 250 (200 mg/50 mg), gélule Modopar 250 (200 mg/50 mg), gélule Modopar 250 (200 mg/50 mg), gélule not available 9800255 ROCHE BULGARIA EOOD BG not available 20020187 ROCHE BULGARIA EOOD BG not available 3400931704355 ROCHE FR not available 3400931704126 ROCHE FR not available 3400931704294 ROCHE FR not available 3400930066553 ROCHE FR not available 3400930066560 ROCHE FR not available 3400930066577 ROCHE FR not available 34009 333 131 2 8 ROCHE FR not available 3400930066669 ROCHE FR not available 3400931704874 ROCHE FR not available 3400931704706 ROCHE FR not available 3400931704935 ROCHE FR not available 3400930066614 ROCHE FR EMA/88406/2018 Page 9/12

Modopar 250 (200 mg/50 mg), gélule Modopar 250 (200 mg/50 mg), gélule Modopar 62,5 (50 mg/12,5 mg), gélule Modopar 62,5 (50 mg/12,5 mg), gélule Modopar L.P. 125 (100 mg/25 mg), gélule a liberation prolongee Modopar L.P. 125 (100 mg/25 mg), gélule a liberation prolongee Modopar L.P. 125 (100 mg/25 mg), gélule a liberation prolongee MODOPAR L.P. 125 100 mg/25 mg, gélule à libération prolongée MODOPAR L.P. 125 100 mg/25 mg, gélule à libération prolongée MODOPAR L.P. 125 100 mg/25 mg, gélule à libération prolongée Prolopa 125, 100 mg/25 mg, capsules, hard Prolopa 125, 100 mg/25 mg, comprimés dispersibles Prolopa 125, 100 mg/25 mg, comprimés dispersibles not available 3400930066591 ROCHE FR not available 3400930066607 ROCHE FR not available 3400932407620 ROCHE FR not available 3400930066546 ROCHE FR not available 3400930066621 ROCHE FR not available 3400930066638 ROCHE FR not available 3400930066652 ROCHE FR not available 3400932985432 ROCHE FR not available 3400932985203 ROCHE FR not available 3400932985371 ROCHE FR not available BE054083 N.V. ROCHE S.A. BE not available BE182226 N.V. ROCHE S.A. BE not available 0178/04068272 N.V. ROCHE S.A. LU EMA/88406/2018 Page 10/12

Prolopa 125, 100 mg/25 not available BE182226 N.V. ROCHE S.A. BE mg, dispergeerbare tabletten Prolopa 125, 100 mg/25 not available BE054083 N.V. ROCHE S.A. BE mg, gélules Prolopa 125, 100 mg/25 not available 0178/86070194 N.V. ROCHE S.A. LU mg, gélules Prolopa 125, 100 mg/25 not available BE054083 N.V. ROCHE S.A. BE mg, Hartkapseln Prolopa 125, 100 mg/25 not available 0178/86070194 N.V. ROCHE S.A. LU mg, Hartkapseln Prolopa 125, 100 mg/25 not available BE182226 N.V. ROCHE S.A. BE mg, Tabletten zur Herstellung einer Suspension zum Einnehmen Prolopa 125, 100 mg/25 not available 0178/04068272 N.V. ROCHE S.A. LU mg, Tabletten zur Herstellung einer Suspension zum Einnehmen Prolopa 250 comprimés not available 0178/04068273 N.V. ROCHE S.A. LU Prolopa 250, 200 mg/50 not available BE132492 N.V. ROCHE S.A. BE mg, comprimés Prolopa 250, 200 mg/50 not available BE132492 N.V. ROCHE S.A. BE mg, tabletten Prolopa 250, 200 mg/50 not available BE132492 N.V. ROCHE S.A. BE mg, Tabletten Prolopa 250, 200 mg/50 not available 0178/04068273 N.V. ROCHE S.A. LU mg, Tabletten Prolopa HBS 125, 100 mg/25 mg, capsules met verlengde afgifte, hard not available BE149475 N.V. ROCHE S.A. BE EMA/88406/2018 Page 11/12

Prolopa HBS 125, 100 mg/25 mg, gélules à libération prolongée Prolopa HBS 125, 100 mg/25 mg, gélules à libération prolongée Prolopa HBS 125, 100 mg/25 mg, Hartkapseln, retardiert Prolopa HBS 125, 100 mg/25 mg, Hartkapseln, retardiert RESTEX 100 mg/25 mg Retardkapseln RESTEX 100 mg/25 mg Tabletten Restex 100 mg/25 mg Tabletten Restex 100 mg/25 mg Hartkapseln, retardiert Мадопар HBS 100 mg/25 mg твърди капсули с удължено освобождаване not available BE149475 N.V. ROCHE S.A. BE not available 0178/04078338 N.V. ROCHE S.A. LU not available BE149475 N.V. ROCHE S.A. BE not available 0178/04078338 N.V. ROCHE S.A. LU DE/H/0371/002 1-25132 ROCHE AUSTRIA GMBH AT DE/H/0371/003 1-25133 ROCHE AUSTRIA GMBH AT DE/H/0371/003 44958.00.02 ROCHE PHARMA AG DE DE/H/0371/002 44958.00.00 ROCHE PHARMA AG DE not available 20030139 ROCHE BULGARIA EOOD BG EMA/88406/2018 Page 12/12